LexisNexis® Legal Newsroom
Sanofi-Aventis Settles 3 Lawsuits Over Eloxatin

PARIS – (AP) Sanofi-Aventis has settled three patent infringement lawsuits in the U.S. related to generic versions of colon cancer treatment Eloxatin, the French drug maker said Thursday. Under terms of the settlements, the three generic drug makers Teva Pharmaceuticals USA, Inc., Fresenius Kabi...

Teva Announces Trial Date In Generic Copaxone Litigation

JERUSALEM - Teva Pharmaceutical Industries Ltd. has announced that the U.S. District Court for the Southern District of New York has set a trial date of Sept. 7, 2011 in the company's ongoing patent infringement litigation against Momenta Pharmaceuticals Inc./Sandoz Inc. and Mylan Pharmaceuticals...

Alabama High Court Vacates $78.4 Million Drug-Pricing Verdict Against Generic Maker Sandoz

MONTGOMERY, Ala. - (Mealey's) In a 7-1 vote, the Alabama Supreme Court on July 13 vacated a $78.4 million drug-pricing verdict against generic drug maker Sandoz Inc., finding that the state government knew that the reported drug prices were not accurate and that the state based its reimbursement...

Kentucky Appeals Court Vacates $130 Million Drug-Pricing Verdicts, Says State Was 'Complicit'

FRANKFORT, Ky. - A Kentucky appeals court panel on Oct. 12 vacated verdicts totaling more than $130.7 million against two drug makers for publishing inflated average wholesale prices (AWPs), saying the Kentucky Medicaid program was well aware of the practice and was complicit in the scheme ( Sandoz Inc...